ResearcherKorea UniversityNo recent work listed
Jun Suk Kim
Matched on ORCID iD 0000-0002-5300-8933; OpenAlex author ID A5102740492. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 15
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers
Papers 5
- Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study. Co-author DOI 10.1111/cas.14264↗
- Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy. Last author DOI 10.3904/kjim.2018.076↗
- Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospec… Last author DOI 10.1186/s12885-018-5154-3↗
- Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report. Last author DOI 10.1186/s12885-016-2616-3↗
- A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer. Last author DOI 10.4143/crt.2012.44.2.127↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hong Jun Kim · 2 shared papers, 2018–2020 · strength 0.20
- Paper Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative … DOI 10.3904/kjim.2018.076↗
- Paper Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with m… DOI 10.1186/s12885-018-5154-3↗
- Jung Sun Kim · 2 shared papers, 2018–2020 · strength 0.20
- Paper Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative … DOI 10.3904/kjim.2018.076↗
- Paper Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with m… DOI 10.1186/s12885-018-5154-3↗
- Hye Jin Choi · 1 shared paper, 2020 · strength 0.10
- Jen‐Shi Chen · 1 shared paper, 2020 · strength 0.10
- Kun‐Ming Rau · 1 shared paper, 2020 · strength 0.10
- Bruce Belanger · 1 shared paper, 2020 · strength 0.10
- Do‐Youn Oh · 1 shared paper, 2020 · strength 0.10
- Li‐Tzong Chen · 1 shared paper, 2020 · strength 0.10
- Chung‐Pin Li · 1 shared paper, 2020 · strength 0.10
- Yung‐Jue Bang · 1 shared paper, 2020 · strength 0.10
- Joon Oh Park · 1 shared paper, 2020 · strength 0.10
- Yan‐Shen Shan · 1 shared paper, 2020 · strength 0.10
- Seong Ji Choi · 1 shared paper, 2016 · strength 0.08
- Young‐Tae Bak · 1 shared paper, 2016 · strength 0.08
- Jong Gwon Choi · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.